Alphagan P Interactions
There are 366 drugs known to interact with Alphagan P (brimonidine ophthalmic), along with 3 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 366 are moderate.
- View all 366 medications that may interact with Alphagan P
- View Alphagan P alcohol/food interactions (1)
- View Alphagan P disease interactions (3)
Most frequently checked interactions
View interaction reports for Alphagan P (brimonidine ophthalmic) and the medicines listed below.
- albuterol
- amlodipine
- aspirin
- atorvastatin
- Cosopt (dorzolamide / timolol ophthalmic)
- dorzolamide / timolol ophthalmic
- doxycycline
- furosemide
- gabapentin
- hydrochlorothiazide
- latanoprost ophthalmic
- levothyroxine
- Lipitor (atorvastatin)
- lisinopril
- losartan
- Lumigan (bimatoprost ophthalmic)
- metformin
- metoprolol
- omeprazole
- prednisone
- simvastatin
- Synthroid (levothyroxine)
- tramadol
- Travatan Z (travoprost ophthalmic)
- trazodone
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Xalatan (latanoprost ophthalmic)
Alphagan P alcohol/food interactions
There is 1 alcohol/food interaction with Alphagan P (brimonidine ophthalmic).
Alphagan P disease interactions
There are 3 disease interactions with Alphagan P (brimonidine ophthalmic) which include:
More about Alphagan P (brimonidine ophthalmic)
- Alphagan P consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (8)
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: ophthalmic glaucoma agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.